Related Experiment Video
Updated: Jan 15, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
Phosphorylation of plectin by Akt3 promotes triple-negative breast cancer cell invasive migration
Shixue Zheng1,2, Chloe Chan1, John M Asara3
1Tung Biomedical Sciences Centre and Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Kowloon, Hong Kong.
Abstract:
Triple-negative breast cancer (TNBC) lacks targeted therapeutics and is aggressive with a poor prognosis. The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, frequently deregulated in cancers, plays crucial roles in tumorigenesis and cancer progression. However, the distinct functions of the three Akt isoforms (Akt1, Akt2, Akt3) in these processes are not well understood. Here, we focus on Akt3, the least-studied Akt isoform, which is overexpressed in 28% of TNBC cases and significantly promotes TNBC growth, stemness, and epithelial-mesenchymal transition. Through a genome-wide proteomic screen, we identified plectin, a member of the plakin family, as an Akt3 substrate in TNBC cells. The depletion of plectin potently inhibits TNBC cell migration and invadopodia formation, albeit with mild effects on cell growth. The phosphorylation of plectin at Ser4268 by Akt promotes its colocalization with vimentin and TNBC cell migration. Our findings underscore the importance of Akt3-plectin signaling as a potential TNBC therapeutic target.
Insights
Researchers identified a new signaling pathway involving Akt3 and plectin that drives triple-negative breast cancer (TNBC) growth and metastasis. Targeting this Akt3-plectin interaction may offer a novel therapeutic strategy for aggressive TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies.
- The PI3K/Akt pathway is crucial in cancer, but isoform-specific roles, especially for Akt3, remain unclear.
- Akt3 is overexpressed in TNBC and linked to tumor progression.
Purpose of the Study:
- To investigate the role of Akt3 in TNBC.
- To identify Akt3 targets in TNBC cells.
- To explore the therapeutic potential of targeting the Akt3 pathway in TNBC.
Main Methods:
- Genome-wide proteomic screening to identify Akt3 substrates.
- Functional assays to assess the impact of plectin depletion on TNBC cells.
- Analysis of plectin phosphorylation and its effect on cell migration and invadopodia.
Main Results:
- Plectin identified as an Akt3 substrate in TNBC.
- Plectin depletion inhibits TNBC cell migration and invadopodia formation.
- Akt3-mediated phosphorylation of plectin promotes TNBC cell migration via vimentin.
Conclusions:
- Akt3 plays a significant role in promoting TNBC growth, stemness, and epithelial-mesenchymal transition.
- The Akt3-plectin signaling axis is critical for TNBC cell migration and invadopodia formation.
- Targeting Akt3-plectin signaling represents a promising therapeutic strategy for TNBC.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Cancer Cell Migration through Invadopodia
Intracellular Signaling Affects Focal Adhesions
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway

